Key Developments in Non-Metastatic & Metastatic Hormone-Sensitive Prostate Cancer from ctc free trial Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 13 min 56 sec ✓ Published: 05-Jun-2018
Description: The group discuss a series of phase II trials, predictive biomarkers and signpost emerging therapies from the congress.The discussion begins with reference to a Scandinavian adjuvant study (SPCG-13). Which was a randomised phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy for intermediate and high risk prostate cancer. The group comments that the trial was negative and did not improve BDFS.nThe panel also highlight the continued data from LATITUDE where a d
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)